BRAIDWELL LP Portfolio

Auto-discovered 13F filer (Top-2000 by latest reported value).

SEC 13F CIK: 0001920938

What is a 13F filing? Who files one and when · What 13F filings can't tell you

MidHealth TiltHigh Turnover how tags are computed

Q1 2026 · 84 positions · Total reported value $2.64B · Top-10 concentration 31.4% · Updated 2026-10-18

Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR

Turnover: 75.0% · 24 new · 32 cut · 25 exited

Active Share (vs S&P 500): 98.9% · vs QQQ: 99.4% — share of the book that differs from index weights (higher = more active) · ranking

Est. Qtr Return (Q1 2026 → Q2 2026): +24.0% · vs SPY +9.2% · Prev Value $2.64B — last quarter positions weighted by this quarter price moves · ranking

In its Q1 2026 13F filing, BRAIDWELL LP disclosed 84 equity positions with a combined reported value of $2.64B. The filing implies a moderately concentrated portfolio: its ten largest positions account for 31.4% of reported value. HoldingsHub classifies the profile as Mid / Health Tilt / High Turnover.

The largest disclosed positions as of Q1 2026 were CAI ($143.21M), NBIX ($85.91M), GKOS ($82.20M). By sector, the heaviest allocations are Health Care 85.4%, Industrials 2.9%. Versus the prior quarter, allocation shifted toward Health Care (+4.5pp) and away from Consumer Staples (-0.7pp), Other (-2.1pp).

Versus the prior quarter, BRAIDWELL LP opened 24 new positions, trimmed 32 and fully exited 25, a turnover rate of 75.0% of positions. The portfolio's overlap with the prior quarter was 55% of names.

The largest new positions opened in Q1 2026 were GENB ($44.91M), RYTM ($27.02M), ESTA ($26.32M).

Of the 25 positions fully exited versus the prior quarter, the largest were TTMI ($72.80M), ALGN ($59.49M), IRWD ($50.47M).

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

New Positions (Q1 2026)

  • GENB GENERATE BIOMEDICINES INC · $44.91M
  • RYTM RHYTHM PHARMACEUTICALS INC · $27.02M
  • ESTA ESTABLISHMENT LABS HLDGS INC · $26.32M
  • CRVS CORVUS PHARMACEUTICALS I · $25.64M
  • ATEC ALPHATEC HLDGS INC · $23.64M
  • DMRA DAMORA THERAPEUTICS INC COM SHS · $23.18M
  • BSX BOSTON SCIENTIFIC CORP · $21.74M
  • BIOA BIOAGE LABS INC · $21.00M

Fully Exited (vs previous quarter)

  • TTMI TTM TECHNOLOGIES INC · prev qtr: $72.80M
  • ALGN ALIGN TECHNOLOGY INC · prev qtr: $59.49M
  • IRWD IRONWOOD PHARMACEUTICALS INC · prev qtr: $50.47M
  • RAPT RAPT THERAPEUTICS INC · prev qtr: $31.49M
  • LEGN LEGEND BIOTECH CORP · prev qtr: $28.22M
  • TERN TERNS PHARMACEUTICALS INC · prev qtr: $23.24M
  • BIIB BIOGEN INC · prev qtr: $20.36M
  • VTYX VENTYX BIOSCIENCES INC · prev qtr: $17.34M

Insider Transactions (Form 4)

Latest BRAIDWELL LP buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.

Fund Profile

Braidwell LP, based in Stamford, CT, United States, files quarterly US equity holdings with the SEC on Form 13F. Its latest filing (Q2 2026) lists 83 positions worth $2.54B in total. HoldingsHub carries 12 quarters of its filings (Q3 2023–Q2 2026).

Firm Snapshot

  • Headquarters: STAMFORD, CT, United States
  • SEC registration: 801-122966 (status: Approved), registered 2022-01-03
  • Regulatory AUM (Form ADV): $3.63B as of 2026-09-22
  • Client mix (by RAUM): pension and profit-sharing plans 100%
  • Manages 12 private funds, of which 11 hedge funds
  • Website: braidwell.com

Portfolio Structure

  • 83 positions · $2.54B reported value (Q2 2026)
  • Top 10 holdings = 32.8% of reported value
  • Largest position: CAI (CARIS LIFE SCIENCES INC) at 5.8%
  • Average position size: $30.62M

Sector Tilt

  • Health Care 90.1%
  • Information Technology 4.3%
  • Industrials 4.3%
  • (classified holdings cover 100% of value)

Quarterly Activity

  • Q2 2026: 24 new, 21 added, 32 reduced, 25 exited
  • 6 positions unchanged

Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.

Sector Allocation

Health Care 85.4%
Technology 2.1%
Financials 0.4%
Other 8.5%
Sort by: Value Shares Weight Sector Change · CSV
# Shares Value Weight Allocation Change
1 8.01M $143.21M 5.42%
5.42%
Add
2 652.12K $85.91M 3.25%
3.25%
Reduce
3 763.50K $82.20M 3.11%
3.11%
Reduce
4 1.99M $78.91M 2.99%
2.99%
Reduce
5 1.34M $77.83M 2.95%
2.95%
Reduce
6 899.36K $75.47M 2.86%
2.86%
Reduce
7 2.35M $73.95M 2.80%
2.80%
Reduce
8 610.19K $72.01M 2.73%
2.73%
Add
9 700.43K $71.76M 2.72%
2.72%
Reduce
10 1.82M $69.33M 2.62%
2.62%
Reduce
11 984.78K $66.65M 2.52%
2.52%
Reduce
12 84.94K $62.03M 2.35%
2.35%
Add
13 1.46M $56.11M 2.12%
2.12%
Add
14 2.47M $55.01M 2.08%
2.08%
Add
15 3.21M $52.75M 2.00%
2.00%
Add
16 182.43K $47.12M 1.78%
1.78%
Reduce
17 932.82K $47.05M 1.78%
1.78%
Reduce
18 499.71K $46.16M 1.75%
1.75%
Reduce
19 92.92K $45.67M 1.73%
1.73%
Add
20 3.59M $44.91M 1.70%
1.70%
New
21 1.49M $44.55M 1.69%
1.69%
Add
22 1.02M $43.32M 1.64%
1.64%
Reduce
23 1.36M $43.01M 1.63%
1.63%
Reduce
24 5.62M $41.68M 1.58%
1.58%
Add
25 478.67K $40.29M 1.52%
1.52%
Reduce
26 539.71K $39.38M 1.49%
1.49%
Add
27 2.17M $37.73M 1.43%
1.43%
Add
28 77.30K $35.63M 1.35%
1.35%
Reduce
29 677.57K $34.95M 1.32%
1.32%
Add
30 105.35K $34.59M 1.31%
1.31%
Reduce
31 329.39K $32.74M 1.24%
1.24%
Add
32 959.26K $32.12M 1.22%
1.22%
Reduce
33 1.68M $30.49M 1.16%
1.16%
Add
34 10.24M $28.98M 1.10%
1.10%
Add
35 229.22K $28.25M 1.07%
1.07%
Reduce
36 337.56K $28.12M 1.06%
1.06%
Reduce
37 497.02K $28.08M 1.06%
1.06%
Reduce
38 1.75M $27.14M 1.03%
1.03%
Reduce
39 310.63K $27.02M 1.02%
1.02%
New
40 139.33K $26.42M 1.00%
1.00%
Add
41 463.60K $26.32M 1.00%
1.00%
New
42 847.15K $26.19M 0.99%
0.99%
Reduce
43 129.00K $25.80M 0.98%
0.98%
Add
44 1.75M $25.64M 0.97%
0.97%
New
45 3.13M $24.04M 0.91%
0.91%
Add
46 3.99M $23.73M 0.90%
0.90%
Add
47 2.17M $23.64M 0.90%
0.90%
New
48 894.85K $23.18M 0.88%
0.88%
New
49 346.47K $21.74M 0.82%
0.82%
New
50 523.82K $21.07M 0.80%
0.80%
Reduce

FAQ

What did BRAIDWELL LP buy in 2026-Q1?

In its 2026-Q1 13F filing, BRAIDWELL LP reported 84 equity positions worth $2.64B in aggregate; its largest disclosed positions were CAI ($143.21M), NBIX ($85.91M), GKOS ($82.20M).

How large is BRAIDWELL LP's portfolio?

BRAIDWELL LP reported $2.64B of long equity holdings across 84 positions as of 2026-Q1. Top-10 holdings account for 31.4% of reported value.

What is BRAIDWELL LP's investment style?

HoldingsHub classifies the portfolio as Mid / Health Tilt / High Turnover, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/braidwell/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →